Total Funding
67
59
Total FundingNon-equity Assistance raised
Growth Score
14 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
28275
Amber Therapeutics develops the next-generation of bioelectrical therapies.
- Tim Denison: Co-Founder, Director, and Chief EngineerPast Role: Medtronic, Vice President of Research and Core Technology
About the Company
Amber Therapeutics develops the next-generation of bioelectrical therapies that can sense and adapt as well as stimulate, with the potential to radically improve clinical outcomes in patients with functional disorders of the peripheral nervous system.
